Leslie Holsinger - Net Worth and Insider Trading

Leslie Holsinger Net Worth

The estimated net worth of Leslie Holsinger is at least $5,880 dollars as of 2024-11-12. Leslie Holsinger is the Executive Vice President of Quince Therapeutics Inc and owns about 3,500 shares of Quince Therapeutics Inc (QNCX) stock worth over $5,880. Details can be seen in Leslie Holsinger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Leslie Holsinger has not made any transactions after 2020-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Leslie Holsinger

To

Leslie Holsinger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leslie Holsinger owns 1 companies in total, including Quince Therapeutics Inc (QNCX) .

Click here to see the complete history of Leslie Holsinger’s form 4 insider trades.

Insider Ownership Summary of Leslie Holsinger

Ticker Comapny Transaction Date Type of Owner
QNCX Quince Therapeutics Inc 2020-12-14 Executive Vice President

Leslie Holsinger Latest Holdings Summary

Leslie Holsinger currently owns a total of 1 stock. Leslie Holsinger owns 3,500 shares of Quince Therapeutics Inc (QNCX) as of December 14, 2020, with a value of $5,880.

Latest Holdings of Leslie Holsinger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QNCX Quince Therapeutics Inc 2020-12-14 3,500 1.68 5,880

Holding Weightings of Leslie Holsinger


Leslie Holsinger Form 4 Trading Tracker

According to the SEC Form 4 filings, Leslie Holsinger has made a total of 1 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 40,000 shares on December 14, 2020, which brought Leslie Holsinger around $1 Million.

Insider Trading History of Leslie Holsinger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Leslie Holsinger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Leslie Holsinger Ownership Network

Ownership Network List of Leslie Holsinger

No Data

Ownership Network Relation of Leslie Holsinger

Insider Network Chart

Leslie Holsinger Owned Company Details

What does Quince Therapeutics Inc do?

Who are the key executives at Quince Therapeutics Inc?

Leslie Holsinger is the Executive Vice President of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .

Quince Therapeutics Inc (QNCX) Insider Trades Summary

Over the past 18 months, Leslie Holsinger made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Quince Therapeutics Inc Insider Transactions

No Available Data

Leslie Holsinger Mailing Address

Above is the net worth, insider trading, and ownership report for Leslie Holsinger. You might contact Leslie Holsinger via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.